Search for: "ALLERGAN, PLC"
Results 1 - 20
of 40
Sorted by Relevance
|
Sort by Date
6 Apr 2016, 7:37 pm
Pfizer Inc. and Allergan PLC withdrew their planned $160 billion merger, ending what would have been the largest so-called inversion transaction. [read post]
19 Feb 2020, 1:03 pm
Federal Trade Commission (“FTC”) raising concerns that the divestiture of Allergan plc’s (“Allergan”) pipeline drug, brazikumab, will not succeed unless the FTC addresses AbbVie’s use of rebate walls. [read post]
6 May 2020, 1:51 pm
’s (“AbbVie”) $63 billion acquisition of Allergan plc (“Allergan”) on the condition that the merging parties divest three minor products. [read post]
21 Dec 2015, 3:00 am
Marian (UC-Irvine), Inversions and Competitiveness: Reflections in the Wake of Pfizer/Allergan: The recent announcement that Pfizer Inc. has reached a merger agreement with Allergan PLC , with the combined entity being tax-resident in Ireland, is a good occasion to reconsider U.S. policy options... [read post]
12 Sep 2019, 2:44 pm
’s (“AbbVie”) acquisition of Allergan plc (“Allergan”). [read post]
5 Jun 2018, 8:04 am
“Judges Criticize Allergan’s Use of Mohawk Tribe’s Sovereignty”: Susan Decker of Bloomberg News has a report that begins, “Allergan Plc faced a skeptical appeals court Monday as the company defended its use of an American Indian tribe’s sovereign immunity to avoid challenges to its patents from generic-drug makers. [read post]
9 Mar 2014, 9:31 pm
Actavis plc et al. 2:14-cv-00188; filed March 6, 2014 in the Eastern District of Texas • Plaintiff: Allergan, Inc. [read post]
13 Dec 2016, 4:15 am
Last week the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) instituted six separate inter partes reviews (IPRs) against patents owned by Allergan plc, which cover RESTASIS®. [read post]
19 Apr 2015, 9:56 pm
• Defendants: Allergan, Inc.; Actavis, PLC.; Allergan Sales, LLC Infringement of U.S. [read post]
30 Nov 2015, 6:11 am
The situation, which ultimately resulted in the acquisition of Allergan by Actavis plc, included a novel structure that involved a “partnership” between Valeant and the investment fund Pershing Square. [read post]
30 Jan 2019, 5:06 am
Besides Purdue Pharma LP, the list of defendants named in NYC’s suit includes long-time opioid manufacturers Allergan Plc, Endo International Plc, Johnson & Johnson, and Teva Pharmaceutical Industries Ltd., and distributors AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp. [read post]
1 Dec 2014, 6:05 am
On November 17, 2014, Allergan, Inc. announced a $66 billion merger agreement with Actavis plc, thwarting the pending $53 billion bid for Allergan by Valeant Pharmaceuticals International Inc. [read post]
26 Sep 2017, 12:46 pm
., Janssen Pharmaceuticals Inc. and Allergan PLC, filed a brief Friday saying they’ve complied with the U.S. [read post]
21 Apr 2022, 3:26 pm
CVS Health Corp. and CVS Pharmacy Inc. will pay the state $484 million, while Teva Pharmaceuticals Industries Ltd. will pay $195 million, Allergan PLC over $134 million, and Endo Health Solutions $65 million. [read post]
21 Dec 2016, 7:18 am
The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) recently instituted six separate inter partes reviews (IPRs) against patents owned by Allergan plc (NYSE: AGN), which cover RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%. [read post]
15 Nov 2015, 9:32 pm
.; Allergan PLC Infringement of U.S. [read post]
1 Sep 2010, 2:25 pm
This consumer protection information is provided by Louisville, Kentucky attorney Will Nefzger, a partner at Bahe Cook Cantley & Jones PLC. [read post]
24 Feb 2018, 10:12 am
CSR PLC, 771 F.3d 1336, 1342 (Fed. [read post]
23 Oct 2021, 4:25 pm
Allergan (Source: SSRN) Prof. [read post]
23 Nov 2015, 2:05 pm
Sales LLC, a subsidiary of pharmaceutical manufacturer Warner Chilcott PLC, has agreed to plead guilty to a felony charge of health care fraud, the Justice Department announced today. [read post]